核苷（酸）类似物治疗慢性ＨＢＶ感染者至ＨＢＶ ＤＮＡ阴转后ＡＬＴ异常的因素分析
Zhongshan Daxue xuebao. Yixue kexue ban, 2014 【目的】 探明慢性乙型肝炎病毒（ＨＢＶ）感染者接受核苷（酸）类似物（ＮＡ）治疗至ＨＢＶ ＤＮＡ降至不可检测水平后，丙氨酸氨基转移酶（ＡＬＴ）仍然异常的高危因素。【方法】２００６年１月至２０１４年２月期间，回顾加前瞻性随访核苷（酸）类似物初始治疗至ＨＢＶ ＤＮＡ阴转（＜２０ ＩＵ／ｍＬ）后的慢性ＨＢＶ感染者（ｎ ＝ ３８８），对比ＡＬＴ复常者（ｎ＝ ２９８）及异常者［ｎ ＝ ９０；定义为在每１ ～ ３个月的随访间隔中，连续２次以上ＡＬＴ ＞ ４０ Ｕ／Ｌ（男）或 ＞ ３５ Ｕ／Ｌ（女）］的临床特征 ...
doaj
[Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLiu ZH, He XM, Xu KX, Yu HB, Chen J.
europepmc +1 more source
[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang ZG +14 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1993 用多聚酶链反应(PCR)技术检测了16例肝细胞性肝癌(HCC)患者癌灶和癌旁双份组织石蜡包埋标本中的乙型肝炎病毒脱氧核糖核酸(HBV-DNA)。以C基因引物扩增HBV-DNA,32份标本中检出率71.87％。以新鲜冷冻肝标本作对照检出率81.25％,二者相比无显著性差别(X~=0.57,P>0.05)。以质粒提取HBV-DNA作灵敏度测定,PCR-EB可达10fg,PCR-SBH可达lag。应用非放射性的地高辛素标记探针作杂交灵敏度达~32P标记探针的水平。
doaj
[Clinical research advances for small-molecule nucleic acid drugs in the treatment of chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang WX +4 more
europepmc +1 more source
丙型肝炎病毒核心抗原在HBV/HCV合并感染者血清中的检测状况及影响因素分析
Zhongshan Daxue xuebao. Yixue kexue ban, 2011 【目的】 探讨丙型肝炎病毒核心抗原(HCVcAg)在乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)合并感染者血清中的检出状况,并分析其影响因素【方法】检测88例慢性丙型肝炎和62例HBV/HCV合并感染患者血清HCVcAg和HCV RNA,对后者血清进行HBV DNAHBeAg检测,分析HCVcAg检出率与HBeAgHBV DNA定量检测关系【结果】 88例慢性丙型肝炎和62例HBV/HCV合并感染者血清HCVcAg的检出率分别是72.7%(64/88)和38.7%(24/62),χ= 17.358,P
doaj
[Advances in basic and experimental diagnostic research on liver diseases in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiChen DB, Yang RF, Chen HS.
europepmc +1 more source
[<i>Yiqi Jiedu</i> Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoWang Z +5 more
europepmc +1 more source
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source